APG Asset Management N.V. lowered its position in CME Group Inc. (NASDAQ:CME – Free Report) by 3.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,250,980 shares of the financial services provider’s stock after selling 42,368 shares during the period. APG Asset Management N.V. owned about 0.35% of CME Group worth $229,478,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of CME. Gold Investment Management Ltd. purchased a new stake in shares of CME Group during the 4th quarter valued at about $26,000. Salomon & Ludwin LLC bought a new stake in CME Group during the first quarter valued at approximately $28,000. Y.D. More Investments Ltd purchased a new stake in CME Group during the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. raised its position in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares during the period. Finally, Asset Dedication LLC boosted its stake in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
Shares of NASDAQ:CME opened at $217.52 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $78.32 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 8.74 and a beta of 0.55. The firm has a fifty day moving average price of $208.65 and a 200 day moving average price of $207.41. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 52.33%.
Analysts Set New Price Targets
Several equities research analysts have recently commented on CME shares. Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Piper Sandler restated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a research report on Tuesday, August 20th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $212.00 to $177.00 in a research report on Tuesday, September 3rd. JPMorgan Chase & Co. increased their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $209.73.
Check Out Our Latest Research Report on CME
Insiders Place Their Bets
In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Should You Invest in Treasury Bills?
- What is a Death Cross in Stocks?
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- How to Invest in the Best Canadian StocksĀ
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.